Home/Pipeline/ArcticZymes Enzyme Portfolio (e.g., UDG, DNase I)

ArcticZymes Enzyme Portfolio (e.g., UDG, DNase I)

Research Use / Molecular Biology Tools

CommercialMarketed

Key Facts

Indication
Research Use / Molecular Biology Tools
Phase
Commercial
Status
Marketed
Company

About ArcticZymes Technologies ASA

ArcticZymes Technologies ASA is a public biotech company that develops and commercializes unique enzymes derived from organisms adapted to the extreme cold of the Arctic. Its core technology platform focuses on cold-adapted enzymes, including nucleases, polymerases, and phosphatases, which offer advantages in molecular biology, diagnostics, and next-generation sequencing workflows. The company operates both a product business for research use and a therapeutic discovery pipeline, with strategic partnerships to expand its market reach. Its mission is to translate the unique properties of Arctic biomolecules into innovative tools and potential medicines.

View full company profile